“Marc Beer Raises Funds For Women’s Health In Boston “March 25, 2019 - Author: steph - No Comments
Marc Beer is a pharmaceutical expert co-founded Renovia Inc., a firm that deals with products for treating pelvic floor disorders. The company closed its series B on August 2018 with a total of 42 million dollars. The company is based in Boston and manufactures a series of diagnostic and therapeutic products for the patients. The products are used in the treatment of disorders like loss of bladder control, which affects quite some women across the globe. Leva is the first Renovia product that received approval by the Food and Drug Administration in April 2018.
Marc Beer has been able to secure funding for series B from Longwood Fund. The initiative was chaired by Missouri-based Ascension Ventures and also advisors from New York. The funding was meant to develop and test other four therapeutic and diagnostic products, including a new generation of the Leva device.
The Renovia Chairman, Marc Beer, did mention in a statement that they are thrilled by the support the reputable healthcare investors who share their vision. They are committed to enhancing the diagnosis and treatment of pelvic floor disorders to improve the lives of millions of the affected population. He also added that when people combine the proprietary sensor with good digital health platforms, patients will have access to valuable information regarding different treatment options available. As a result, the patients will have an understanding of the pelvic floor disorders, and the cost of healthcare will be reduced significantly.
Marc Beer has more than 26 years of experience in commercialization and development of pharmaceuticals, biotechnology, diagnostics and laboratory devices. He founded Renovia with Yolanda Lorie, Ramon Iglesias and MD in 2016. They succeeded to close Series A financing plan and had funds to lead in healthcare venture. Earlier on, Marc was the founding CEO of ViaCELL, a company that deals with preservation, collection and developing of umbilical cord blood stem cells. He led the firm for seven years and ensured it grew to a giant it is today.
Marc has also served in Erytech Pharma Biopharmaceutical Company as a member of the Board of Directors. He held top positions in Genzyme and recently served as the Vice President of Global Marketing. Marc Beer has ensured commercial launching of various products that are manufactured and approved to deal with rare diseases globally. He has also held sales and marketing roles in the diagnostic and pharmaceutical divisions of Abbott Laboratories. Marc is also a member of the Business Advisory Council of Miami University. Learn more: https://www.bizjournals.com/boston/news/2018/08/21/ex-aegerion-chief-beer-raises-42m-for-womens.html